Session Duration: 2 hours
Format: Lecture, contract analysis, individual drafting of legal clauses
Technology licensing is not just a technical or financial transaction,it is deeply embedded in a legal and commercial framework that governs the behavior, responsibilities, and rights of both the licensor and the licensee. Ignoring or underestimating these considerations can lead to serious legal disputes, regulatory violations, or commercial failures. As such, every licensing agreement must include provisions that anticipate legal risks and protect the commercial integrity of the transaction. Below are the most critical legal and commercial considerations to address in every technology licensing agreement:
1. Confidentiality and Non-Disclosure Clauses: One of the cornerstones of technology licensing is the protection of confidential information. During negotiations and after the agreement is signed, the licensor often shares technical data, experimental results, processes, or business strategies that must remain confidential. A confidentiality clause, often formalized in a Non-Disclosure Agreement (NDA), ensures that such information is not disclosed to third parties or used beyond the agreed scope. It typically defines:
a) What information is considered confidential,
b) The duration of confidentiality obligations (commonly 3 to 10 years),
c) Permitted disclosures (e.g., to employees, investors under similar obligations),
d) Remedies for breach (e.g., injunctive relief or damages).
For public institutions, especially universities and councils, confidentiality is crucial when the technology has not yet been patented or when partners include private firms with competing interests.
2. Export Control and Regulatory Compliance: In many cases, the licensed technology may be subject to export control laws or other national regulations, especially if it has potential military, agricultural, or health-related applications. The licensor must understand whether local or international laws restrict the transfer or sale of the technology to certain regions, organizations, or countries. For example, biotechnology tools developed in a Nigerian research institute might be prohibited for export to countries under international sanctions. In such cases, the agreement must:
a) Identify any applicable export restrictions,
b) Assign responsibility for obtaining necessary licenses or approvals,
c) Include clauses that terminate the agreement if regulatory violations occur.
Failure to comply can result in severe penalties, including loss of funding, blacklisting by international partners, or criminal charges.
3. Patent Prosecution and Maintenance Responsibilities: When licensing patented technology, or technology that is expected to be patented, one key question is who bears the cost and responsibility of managing the patent. This includes:
a) Filing the patent application in different countries,
b) Responding to examiner objections,
c) Paying maintenance or renewal fees.
In many cases, the licensor retains these responsibilities but may allow the licensee to manage prosecution in foreign markets at their own cost. It’s critical to specify:
a) Who pays for what,
b) Who has the authority to make legal decisions about the patent,
c) Whether the licensee is allowed to file improvements or derivative patents,
d) How costs are shared in jurisdictions where both parties have commercial interests
Mismanagement of patents, such as missed renewals or poorly filed applications, can invalidate IP rights and undermine commercialization efforts.
4. Enforcement and Infringement Handling: Another major consideration is how infringement will be handled. If a third party copies or illegally uses the licensed technology, who is responsible for taking legal action? The agreement should define:
a) Whether the licensor or licensee has standing to sue for infringement,
b) Who bears the cost of litigation,
c) How recovered damages are shared,
d) Whether the licensee is obligated to notify the licensor of known infringement.
In some exclusive licenses, the licensee may be expected to defend the IP rights in specific territories, while in non-exclusive licenses, the licensor may retain full enforcement authority. Without clarity, both parties may either neglect enforcement or duplicate efforts inefficiently.
5. Assignment and Change of Control Clauses: Technology licensing agreements must anticipate the possibility of organizational changes, such as mergers, acquisitions, or restructuring. An assignment clause defines whether the license can be transferred to another party, such as a new owner of the licensee, or whether it terminates automatically upon such change. For public institutions, this clause is crucial to ensure that control over publicly funded IP does not unintentionally shift to a private entity without consent. For example, a licensee acquired by a multinational may change the original intentions of the licensing agreement, perhaps shifting production abroad or changing the target market. Assignment clauses usually require the licensor’s written consent before the licensee can transfer their rights.
6. Dispute Resolution Mechanisms: Disagreements are inevitable in long-term partnerships. Including a dispute resolution clause helps resolve issues without resorting to costly and time-consuming court battles. Key issues to define include:
a) Jurisdiction: Which country’s laws will apply?
b) Venue: Where will disputes be heard?
c) Method: Will disputes be resolved via arbitration, mediation, or litigation?
d) Language: Which language will be used in proceedings?
For international agreements, arbitration is often preferred due to its confidentiality and speed. Councils and universities should also consider aligning their dispute processes with their internal legal policies or the laws of the host country.
7. Force Majeure and Termination Provisions: The agreement must also include force majeure clauses that cover unexpected events such as war, pandemics, or natural disasters that prevent performance. Additionally, termination clauses define the conditions under which either party can end the agreement, for instance, breach of contract, insolvency, or failure to meet sales targets. Termination provisions should include:
a) Notice periods (e.g., 60 days),
b) Cure periods to remedy any breach,
c) Post-termination obligations (e.g., return of confidential materials, continued royalties on stock sold after termination).
Such clauses protect both parties from unforeseen risks and provide legal clarity if the relationship needs to end prematurely. Legal and commercial considerations are not optional extras in technology licensing, they are the legal guardrails that ensure the transaction is enforceable, ethical, and financially viable. For West African innovation funding councils, integrating these clauses into every licensing agreement will ensure institutional IP is protected, national interests are upheld, and commercial partners act in good faith. Failure to address these areas can result in IP loss, commercial failure, or reputational damage to the public institution.
Case Studies for Discussion
1. Biofix (Kenya)
Discuss the university-led initiative in producing organic fertilizer, the challenges faced under in-house production, and the impact of transitioning to an industry partner.
2. Smuscan and Smugel (Kenya)
Explore the manufacturing collaboration between Universal Ltd and a research institute and the importance of clear IP and manufacturing agreements.
Individual Assignment: Select a piece of research or innovation from your institution and outline a commercialization plan. Include:
1. Type of IP involved.
2. Licensing or commercialization pathway.
3. Market analysis (SWOT).
4. Proposed partners or investors.
5. Legal considerations.
Group Assignment: Each group is tasked with developing a mock business plan for a university spin-out that will produce and distribute a low-cost medical diagnostic kit to rural clinics in West Africa.
Commercializing research results ensures innovation reaches society and contributes to economic development. Institutions must strategically manage their IP, evaluate markets, and select the right pathway, whether licensing, start-up, or joint venture, to maximize impact. Commercialization strategies are most effective when they benefit the widest possible segment of society. Integrating Gender Equality and Social Inclusion (GESI) considerations ensures that research-derived innovations are not only profitable but also equitable. Module 4 builds directly on the commercialization pathways discussed in Module 3 by emphasizing how to design, implement, and evaluate research and innovation processes so that women, marginalized groups, and underrepresented stakeholders share in the benefits. This transition marks a shift from purely technical and market-oriented approaches to ones that are also socially responsive and inclusive.
Facilitator Notes
a) Use a mock MoU/contract review exercise.
b) Highlight dispute resolution, IP ownership, and compliance.
c) Stress due diligence and legal safeguards.
Suggestions for Further Reading
a) IP Australia (2019). Commercialisation Guide.
b) Hagedoorn, J., & Zobel, A. (2015). “Contract Law and Technology Licensing.” Research Policy, 44(5).